246 related articles for article (PubMed ID: 22200595)
1. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths.
Wang K; Wang Y; Yan X; Chen H; Ma G; Zhang P; Li J; Li X; Zhang J
Bioorg Med Chem Lett; 2012 Jan; 22(2):937-41. PubMed ID: 22200595
[TBL] [Abstract][Full Text] [Related]
2. Selenium-containing naphthalimides as anticancer agents: design, synthesis and bioactivity.
Zhao L; Li J; Li Y; Liu J; Wirth T; Li Z
Bioorg Med Chem; 2012 Apr; 20(8):2558-63. PubMed ID: 22436386
[TBL] [Abstract][Full Text] [Related]
3. Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.
Tan S; Yin H; Chen Z; Qian X; Xu Y
Eur J Med Chem; 2013 Apr; 62():130-8. PubMed ID: 23353750
[TBL] [Abstract][Full Text] [Related]
4. Naphthalimide intercalators with chiral amino side chains: effects of chirality on DNA binding, photodamage and antitumor cytotoxicity.
Yang Q; Yang P; Qian X; Tong L
Bioorg Med Chem Lett; 2008 Dec; 18(23):6210-3. PubMed ID: 18930399
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives.
Li S; Xu S; Tang Y; Ding S; Zhang J; Wang S; Zhou G; Zhou C; Li X
Bioorg Med Chem Lett; 2014 Jan; 24(2):586-90. PubMed ID: 24370011
[TBL] [Abstract][Full Text] [Related]
6. Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1-c][1,4]benzodiazepine-naphthalimide conjugates linked through piperazine side-armed alkane spacers.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2008 Aug; 16(15):7218-24. PubMed ID: 18656370
[TBL] [Abstract][Full Text] [Related]
7. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
8. The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage.
Li X; Lin Y; Wang Q; Yuan Y; Zhang H; Qian X
Eur J Med Chem; 2011 Apr; 46(4):1274-9. PubMed ID: 21345546
[TBL] [Abstract][Full Text] [Related]
9. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
Chen Z; Cao R; Shi B; Yi W; Yu L; Song H; Ren Z; Peng W
Bioorg Med Chem Lett; 2010 Jul; 20(13):3876-9. PubMed ID: 20627721
[TBL] [Abstract][Full Text] [Related]
11. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
[TBL] [Abstract][Full Text] [Related]
12. Sulfur-substituted naphthalimides as photoactivatable anticancer agents: DNA interaction, fluorescence imaging, and phototoxic effects in cultured tumor cells.
Ott I; Xu Y; Liu J; Kokoschka M; Harlos M; Sheldrick WS; Qian X
Bioorg Med Chem; 2008 Aug; 16(15):7107-16. PubMed ID: 18644732
[TBL] [Abstract][Full Text] [Related]
13. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
Wu A; Xu Y; Qian X
Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes.
Bollini M; Casal JJ; Bruno AM
Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786
[TBL] [Abstract][Full Text] [Related]
15. A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis.
Chen Z; Liang X; Zhang H; Xie H; Liu J; Xu Y; Zhu W; Wang Y; Wang X; Tan S; Kuang D; Qian X
J Med Chem; 2010 Mar; 53(6):2589-600. PubMed ID: 20170164
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
17. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
Wu A; Xu Y; Qian X; Wang J; Liu J
Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
[TBL] [Abstract][Full Text] [Related]
18. Molecular design, chemical synthesis, and biological evaluation of '4-1' pentacyclic aryl/heteroaryl-imidazonaphthalimides.
Li F; Cui J; Guo L; Qian X; Ren W; Wang K; Liu F
Bioorg Med Chem; 2007 Aug; 15(15):5114-21. PubMed ID: 17532640
[TBL] [Abstract][Full Text] [Related]
19. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents.
Verma M; Luxami V; Paul K
Eur J Med Chem; 2013 Oct; 68():352-60. PubMed ID: 23994328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
